Sana Biotechnology
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $15,282 |
Gross Profit | -2,857 | -3,649 | 7,641 | |
EBITDA | -38,961 | -47,507 | -46,981 | -45,173 |
EBIT | -42,152 | -50,364 | -50,630 | -50,866 |
Net Income | -42,152 | -93,800 | -49,389 | -49,069 |
Net Change In Cash | 0 | 0 | 0 | 15,282 |
Free Cash Flow | -29,470 | -32,989 | -48,793 | -47,597 |
Cash | 103,357 | 71,271 | 96,131 | 127,566 |
Basic Shares | 260,494 | 238,409 | 237,578 | 236,299 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15,491 | -30,865 | -27,731 | -17,914 |
EBITDA | -255,332 | -268,584 | -256,939 | -345,839 |
EBIT | -272,723 | -293,141 | -272,564 | -356,909 |
Net Income | -266,759 | -283,255 | -266,388 | -344,182 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -74,575 | 134,899 | ||
Free Cash Flow | -256,583 | -273,614 | -310,926 | -280,916 |
Cash | 127,566 | 133,517 | 176,765 | 253,029 |
Basic Shares | 230,891 | 194,541 | 188,344 | 166,433 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.15 |
2025-06-30 | -$0.39 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.23 |
